Recombinant Mouse Ceramide synthase 2 (Cers2)

What is Ceramide synthase 2 (Cers2) and what is its primary function in biological systems?

Ceramide synthase 2 (Cers2) is an enzyme that catalyzes the transfer of acyl chains from acyl-CoA to sphingoid bases, producing ceramides with specific acyl chain lengths. It shows high selectivity toward very-long-chain fatty acyl-CoAs, particularly those with chain lengths of C22-C27. In mammals, Cers2 is part of a family of six ceramide synthases (Cers1-6), each with distinct substrate preferences and tissue distribution patterns. The primary function of Cers2 is to generate very-long-chain ceramides, which serve as essential components of complex sphingolipids involved in membrane structure and cellular signaling pathways .

To study Cers2 function, researchers typically use recombinant protein expression systems, gene knockout models, or overexpression studies. The recombinant protein approach allows for controlled in vitro analysis of enzymatic activity, while genetic models provide insights into physiological roles in vivo.

How does the structure of Cers2 relate to its catalytic function?

Cers2 is a transmembrane protein primarily localized to the endoplasmic reticulum. The human canonical protein consists of 380 amino acid residues with a molecular weight of approximately 44.9 kDa . The protein contains multiple transmembrane domains and a catalytic domain known as the Lag1p motif, which is essential for ceramide synthase activity.

The structural features of Cers2 that contribute to its substrate specificity for very-long-chain acyl-CoAs remain an active area of research. Current evidence suggests that specific amino acid residues within the catalytic domain create a binding pocket that preferentially accommodates C22-C27 acyl chains. Researchers investigating structure-function relationships often use site-directed mutagenesis of recombinant Cers2 to identify critical residues involved in substrate recognition and catalytic activity.

What is the expression pattern of Cers2 across different tissues and how does this inform its biological role?

Cers2 exhibits a broad expression pattern across multiple tissues. In humans, high expression levels are reported in the kidney, liver, brain, heart, placenta, and lung . Within the brain, Cers2 is predominantly expressed in oligodendrocytes rather than neurons, which is significant for understanding its role in central nervous system biology .

This distinct expression pattern suggests tissue-specific functions for Cers2-generated ceramides. For instance, the high expression in liver correlates with the abundance of very-long-chain sphingolipids in this tissue, which are crucial for maintaining proper membrane properties of hepatocytes. Similarly, Cers2 expression in oligodendrocytes contributes to the production of specialized sphingolipids required for myelin structure and function.

Researchers studying tissue-specific roles should consider using conditional knockout models that target Cers2 deletion in specific cell types rather than global knockouts, which may have widespread and complex phenotypes.

What transgenic mouse models are available for studying Cers2 function and what are their key phenotypes?

Several transgenic mouse models have been developed to study Cers2 function:

• Cers2 knockout mice (Cers2-/-): These mice show complete absence of Cers2 expression and exhibit multiple phenotypes including reduced body size, hepatic dysfunction, and myelin abnormalities.

• Cers1to/to;Tg-Cers2 mice: This model features ectopic expression of Cers2 in neurons of Cers1 mutant mice. Interestingly, while Cers1 deficiency leads to neurodegeneration, the addition of the Cers2 transgene suppresses this phenotype, suggesting functional compensation between ceramide synthases under certain conditions .

When working with these models, researchers should consider the following methodological approaches:

• Confirm genotype using PCR and verify protein expression levels using Western blotting

• Conduct lipid profiling using mass spectrometry to characterize changes in sphingolipid composition

• Employ tissue-specific analyses to identify cell-autonomous versus non-cell-autonomous effects

How does ectopic expression of Cers2 affect sphingolipid metabolism in neuronal cells?

Ectopic expression of Cers2 in neurons, which normally express primarily Cers1, leads to significant alterations in sphingolipid metabolism. Research with the Cers1to/to;Tg-Cers2 mouse model revealed that neuronal Cers2 expression did not significantly change the total level or fatty acyl chain length profiles of ceramides and sphingomyelins compared to the Cers1 mutant .

• Significant elevation of C22 and C24:1 hexosylceramides

• Increase in total hexosylceramide levels

• Significant increase in C22 and C24 lactosylceramide species

These findings suggest that the very-long-chain ceramides produced by ectopically expressed Cers2 are preferentially channeled into glycosphingolipids rather than sphingomyelin . This selective incorporation indicates distinct metabolic fates for different ceramide species based on their acyl chain length, which has important implications for understanding the role of specific ceramides in neuronal function and neuropathology.

Researchers studying the effects of Cers2 expression should employ comprehensive lipidomic analyses to capture the complex changes across multiple sphingolipid classes rather than focusing solely on ceramide levels.

What is the role of Cers2-generated ceramides in immune cell function and inflammatory responses?

Cers2 plays a significant role in immune cell function, particularly in neutrophil migration and inflammatory responses. Studies in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, have shown that ablation of Cers2 suppresses EAE pathology by reducing neutrophil migration into the central nervous system .

The mechanism involves G-CSF signaling, which normally leads to a cascade including:

• Phosphorylation of Lyn kinase and STAT3

• Regulation of chemokine receptor 2 (CXCR2) expression

• Translocation of the receptor into detergent-resistant membranes (DRMs)

In Cers2 null bone marrow cells (BMCs), G-CSF fails to induce translocation of G-CSF receptor (G-CSF-R) into DRMs, leading to reduced phosphorylation of Lyn and reduced CXCR2 expression . This demonstrates that very-long-chain ceramides generated by Cers2 are critical for proper G-CSF signaling and neutrophil function.

For researchers studying immune cell function, methods to consider include:

• Flow cytometry to assess cell surface receptor expression

• Membrane fractionation to analyze protein localization in DRMs

• Phospho-specific Western blotting to evaluate signaling pathway activation

• In vitro and in vivo migration assays to assess functional consequences

What expression systems are optimal for producing functional recombinant mouse Cers2?

For producing functional recombinant mouse Cers2, several expression systems have been successfully employed, each with distinct advantages:

• Mammalian expression systems (e.g., HEK293T cells): These provide proper post-translational modifications and membrane insertion, resulting in highly active enzyme. Human recombinant Cers2 has been successfully expressed in HEK293T cells with C-Myc/DDK tags, yielding protein with a predicted molecular weight of 44.7 kDa .

• Insect cell systems (e.g., Sf9 cells): These provide high expression levels while maintaining most post-translational modifications required for activity.

• Yeast expression systems: Useful for functional complementation studies, as yeast have simpler sphingolipid metabolism.

For optimal expression of functional Cers2, researchers should consider:

• Using full-length cDNA with intact transmembrane domains

• Including epitope tags (e.g., C-Myc/DDK) for purification and detection

• Employing detergent extraction methods optimized for membrane proteins

• Verifying enzyme activity using in vitro assays with appropriate acyl-CoA substrates

What are the optimal conditions for purification, storage, and handling of recombinant Cers2?

Proper handling of recombinant Cers2 is critical for maintaining its enzymatic activity:

Purification:

• Affinity chromatography using anti-tag antibodies (e.g., anti-DDK) followed by conventional chromatography steps

• Gentle detergent solubilization to maintain protein structure and activity

• Inclusion of protease inhibitors throughout the purification process

Buffer Conditions:

• 25 mM Tris-HCl, 100 mM glycine, pH 7.3, 10% glycerol

• The addition of glycerol helps stabilize the protein structure

Storage:

• Store at -80°C for long-term preservation

• Avoid repeated freeze-thaw cycles, as these can lead to protein denaturation and loss of activity

• Aliquot the protein solution before freezing to minimize freeze-thaw cycles

Handling:

• For cell culture applications, filter the protein solution before use (note that some protein loss may occur during filtration)

• Maintain protein concentration >0.05 μg/μL for stability

• Verify protein purity (>80%) using SDS-PAGE and Coomassie blue staining

What are the most effective analytical techniques for studying Cers2-generated sphingolipids?

Several analytical techniques are particularly valuable for studying Cers2-generated sphingolipids:

• Liquid Chromatography-Mass Spectrometry (LC-MS/MS):

  • Provides detailed characterization of sphingolipid species

  • Enables quantification of ceramides with different acyl chain lengths

  • Can detect changes in both ceramides and complex sphingolipids derived from them

• Thin Layer Chromatography (TLC):

  • Useful for rapid screening of major sphingolipid classes

  • Can be combined with radioactive labeling for metabolic studies

• Fluorescence-based assays:

  • Utilize fluorescently labeled sphingoid bases to track ceramide synthesis

  • Allow for high-throughput screening applications

When analyzing sphingolipids in biological samples, researchers should:

• Include internal standards for accurate quantification

• Consider extraction methods that efficiently recover very-long-chain sphingolipids

• Analyze both simple sphingolipids (ceramides) and complex sphingolipids (sphingomyelins, hexosylceramides, lactosylceramides)

• Compare profiles across multiple sphingolipid classes to understand metabolic channeling

How can researchers effectively design experiments to study the specific role of Cers2 in membrane organization?

To study Cers2's role in membrane organization, researchers should consider the following experimental approaches:

• Detergent-resistant membrane (DRM) isolation:

  • Useful for studying protein localization in membrane microdomains

  • Critical for understanding how Cers2-generated ceramides affect receptor signaling

  • Has revealed that G-CSF receptor translocation into DRMs depends on Cers2-generated very-long-chain ceramides

• Membrane fluidity and biophysical studies:

  • Techniques such as fluorescence anisotropy or fluorescence recovery after photobleaching (FRAP)

  • Atomic force microscopy to examine membrane domain formation

  • Analysis of lipid packing in model membranes with defined ceramide compositions

• Protein-lipid interaction studies:

  • Lipidomic analysis of immunoprecipitated membrane proteins

  • Lipid overlay assays to identify proteins that bind specifically to very-long-chain ceramides

  • Photoactivatable lipid analogs for in situ identification of ceramide-interacting proteins

Experimental design considerations should include:

• Comparison between wild-type and Cers2-deficient cells/tissues

• Use of specific inhibitors that target Cers2 without affecting other ceramide synthases

• Analysis of effects on membrane protein clustering and lateral mobility

What is the relationship between Cers2 activity and other sphingolipid metabolic enzymes?

Cers2 functions within a complex network of sphingolipid metabolic enzymes, and its activity can influence and be influenced by other enzymes in the pathway:

• Substrate competition:

  • Cers2 competes with other ceramide synthases (Cers1-6) for sphingoid base substrates

  • Changes in Cers2 expression can alter substrate availability for other ceramide synthases

• Metabolic channeling:

  • Cers2-generated very-long-chain ceramides are preferentially incorporated into glycosphingolipids rather than sphingomyelins

  • This suggests coordination between Cers2 and specific glycosphingolipid synthases

• Compensatory mechanisms:

  • Ectopic expression of Cers2 can partially compensate for Cers1 deficiency in neurons, suggesting functional overlap despite different substrate preferences

  • This compensatory effect likely involves complex cross-talk between different branches of sphingolipid metabolism

To study these relationships, researchers should:

• Perform comprehensive lipidomic analyses across multiple sphingolipid classes

• Use genetic models with manipulation of multiple sphingolipid enzymes

• Conduct metabolic labeling studies to track the flow of metabolites through different pathways

• Analyze enzyme expression levels to identify compensatory transcriptional responses

How does Cers2 function relate to neurodegenerative disease models?

Cers2 has important implications for neurodegenerative disease research:

• Protective effects in neurodegeneration:

  • Ectopic expression of Cers2 in neurons suppresses the neurodegenerative phenotype observed in Cers1-deficient mice

  • This suggests potential therapeutic applications for modulating ceramide synthase activity in neurodegenerative conditions

• Impact on sphingolipid profiles:

  • In Cers1to/to;Tg-Cers2 mice, neuronal Cers2 expression significantly alters hexosylceramide and lactosylceramide profiles without substantially changing ceramide levels

  • This indicates that the protective effect may be related to changes in complex sphingolipids rather than ceramides themselves

• Experimental autoimmune encephalomyelitis (EAE) models:

  • Ablation of Cers2 suppresses EAE pathology by reducing neutrophil migration into the central nervous system

  • This demonstrates a role for Cers2 in neuroinflammatory processes relevant to multiple sclerosis

Methodological approaches for studying Cers2 in neurodegenerative contexts include:

• Behavioral testing to assess neurological function

• Histopathological analysis of neuronal loss and inflammation

• Electrophysiological studies to measure neuronal activity

• Cell-type-specific manipulation of Cers2 expression to distinguish direct versus indirect effects

Comparative properties of recombinant Cers2 protein preparations

Data compiled from available recombinant protein specifications .

Sphingolipid changes in Cers2 transgenic mouse models

Data summarized from experimental findings in transgenic mouse models .